Literature DB >> 10445521

The metabolic consequences of slow colonic transit.

S J Lewis1, K W Heaton.   

Abstract

Intestinal transit has a substantial influence on the enterohepatic circulation of bile acids and steroid hormones, on colonic pH, and on short chain fatty acid concentrations in the distal colon. Slow transit is likely to favor disease processes that are related to over-efficient enterohepatic recirculation and to lack of short chain fatty acid in the distal colon. These include gallstones, large bowel cancer, and possibly breast cancer. The best-documented influence of slow colonic transit is on bile acid metabolism. Slowing colonic transit increases deoxycholate and raises cholesterol saturation of bile, making gallstone formation more likely. In this review, we also examine the evidence that slow colonic transit may be important in the etiology of large bowel and breast cancer. There is a lack of data pertaining to the relationship between colonic transit and diseases such as colon and breast cancer. Should slow colonic transit prove to be a significant factor in the etiology of such diseases, then the health of the population might benefit from dietary and lifestyle changes that speed up intestinal transit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445521     DOI: 10.1111/j.1572-0241.1999.01271.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome.

Authors:  Jose M Bruno-Barcena; M Andrea Azcarate-Peril
Journal:  J Funct Foods       Date:  2015-01       Impact factor: 4.451

2.  Temporal and spatial changes in cell wall composition in developing grains of wheat cv. Hereward.

Authors:  G A Toole; G Le Gall; I J Colquhoun; C Nemeth; L Saulnier; A Lovegrove; T Pellny; M D Wilkinson; J Freeman; R A C Mitchell; E N C Mills; P R Shewry
Journal:  Planta       Date:  2010-06-13       Impact factor: 4.116

3.  A prospective study of bowel motility and related factors on breast cancer risk.

Authors:  Sonia S Maruti; Johanna W Lampe; John D Potter; Ann Ready; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

4.  Production and cytomolecular identification of new wheat-perennial rye (Secale cereanum) disomic addition lines with yellow rust resistance (6R) and increased arabinoxylan and protein content (1R, 4R, 6R).

Authors:  Annamária Schneider; Marianna Rakszegi; Márta Molnár-Láng; Éva Szakács
Journal:  Theor Appl Genet       Date:  2016-02-16       Impact factor: 5.699

Review 5.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

6.  Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.

Authors:  Philip A Waller; Pramod K Gopal; Gregory J Leyer; Arthur C Ouwehand; Cheryl Reifer; Morgan E Stewart; Larry E Miller
Journal:  Scand J Gastroenterol       Date:  2011-06-13       Impact factor: 2.423

7.  Incidence of gall stone formation in acromegalic patients on octreotide therapy.

Authors:  Aditi A Chakravarty; Ajay Ajmani; Smita Manchanda; Bindu Kulshreshtha; Shweta Chopra
Journal:  Indian J Endocrinol Metab       Date:  2012-05

8.  Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist--tegaserod.

Authors:  Ronald Mathison; Eldon Shaffer
Journal:  BMC Gastroenterol       Date:  2006-02-23       Impact factor: 3.067

Review 9.  Cereal-based gluten-free food: how to reconcile nutritional and technological properties of wheat proteins with safety for celiac disease patients.

Authors:  Carmela Lamacchia; Alessandra Camarca; Stefania Picascia; Aldo Di Luccia; Carmen Gianfrani
Journal:  Nutrients       Date:  2014-01-29       Impact factor: 5.717

10.  Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.

Authors:  Kim E Innes; Jeffrey H Wimsatt; Stephanie Frisbee; Alan M Ducatman
Journal:  BMC Cancer       Date:  2014-01-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.